Webster J L, Polgar W E, Brandt S R, Berzetei-Gurske I P, Toll L
SRI International, Menlo Park, CA.
Eur J Pharmacol. 1993 Feb 9;231(2):251-8. doi: 10.1016/0014-2999(93)90457-s.
The presence of kappa-opioid receptor subtypes has been clearly established in guinea pig brain. Using [3H]bremazocine in the presence of reversible blockers of mu, delta and kappa 1 receptors, two additional binding sites can be determined in guinea pig brain membranes. The site with higher affinity for the opioid ligands represents kappa 2, while the other site has low affinity and is poorly characterized. The kappa 2 site has high affinity for ethylketocyclazocine and other benzomorphans, as well as for the dynorphin gene products tested. The dynorphin analogs have no appreciable affinity for the low affinity site, so this site should not be called a kappa receptor. With an appropriate membrane preparation, kappa 2 binding can also be demonstrated in the guinea pig ileum. Binding affinities for selected ligands at kappa 2 in guinea pig ileum membranes are very similar to affinities found in brain membranes.
豚鼠脑中已明确存在κ-阿片受体亚型。在存在μ、δ和κ1受体可逆性阻断剂的情况下,使用[3H]布瑞马唑辛,可在豚鼠脑膜中确定另外两个结合位点。对阿片样物质配体具有较高亲和力的位点代表κ2,而另一个位点亲和力较低且特性不明确。κ2位点对乙基酮环唑新和其他苯并吗啡烷以及所测试的强啡肽基因产物具有高亲和力。强啡肽类似物对低亲和力位点没有明显亲和力,因此该位点不应称为κ受体。通过适当的膜制备方法,在豚鼠回肠中也可证明κ2结合。豚鼠回肠膜中κ2位点对选定配体的结合亲和力与在脑膜中发现的亲和力非常相似。